Seminars in Oncology
Volume 32, Issue 1 , Pages 43-51 , February 2005

Oral capecitabine: Bridging the Atlantic divide in colon cancer treatment

  • Eric Van Cutsem

      Affiliations

    • University Hospital Gasthuisberg, Department of Internal Medicine, Digestive Oncology Unit, Leuven, Belgium.
    • Corresponding Author InformationAddress reprint requests to Eric Van Cutsem, MD, PhD, University Hospital Gasthuisberg, Department of Internal Medicine, Herestraat 49, Leuven 3000, Belgium.
    • ,
  • Chris Verslype

      Affiliations

    • University Hospital Gasthuisberg, Department of Internal Medicine, Digestive Oncology Unit, Leuven, Belgium.
    • ,
  • Sabine Tejpar

      Affiliations

    • University Hospital Gasthuisberg, Department of Internal Medicine, Digestive Oncology Unit, Leuven, Belgium.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(04)00457-9

doi: 10.1053/j.seminoncol.2004.09.028

Seminars in Oncology
Volume 32, Issue 1 , Pages 43-51 , February 2005

Article Tools

* Image Usage & Resolution